Ahmed Kamal Selected Research

Imines

1/2018	Development of pyrrolo[2,1-c][1,4]benzodiazepine β-glucoside prodrugs for selective therapy of cancer.
5/2008	Development of pyrrolo[2,1-c][1,4]benzodiazepine beta-galactoside prodrugs for selective therapy of cancer by ADEPT and PMT.
10/2004	Design, synthesis, and evaluation of mixed imine-amine pyrrolobenzodiazepine dimers with efficient DNA binding affinity and potent cytotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ahmed Kamal Research Topics

Disease

98	Neoplasms (Cancer) 03/2022 - 08/2002
17	Breast Neoplasms (Breast Cancer) 01/2022 - 06/2010
12	Lung Neoplasms (Lung Cancer) 01/2022 - 10/2014
6	Inflammation (Inflammations) 02/2022 - 01/2002
6	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 08/2012
6	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 05/2015
5	Hepatocellular Carcinoma (Hepatoma) 02/2022 - 05/2008
5	Colonic Neoplasms (Colon Cancer) 01/2021 - 10/2015
4	Melanoma (Melanoma, Malignant) 01/2021 - 07/2010
3	Chronic Hepatitis C 03/2021 - 01/2018
3	Tuberculosis (Tuberculoses) 09/2015 - 02/2006
2	Fibrosis (Cirrhosis) 02/2022 - 03/2021
2	Hepatitis C 03/2021 - 01/2018
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2019 - 08/2018
2	Carcinoma (Carcinomatosis) 01/2019 - 01/2016
2	Macular Edema 01/2018 - 01/2015
2	Uveitis 01/2018 - 01/2015
2	Chronic Pain 01/2016 - 05/2014
1	Liver Cirrhosis (Hepatic Cirrhosis) 04/2022
1	Liver Diseases (Liver Disease) 09/2021
1	Vitiligo 09/2021
1	Diabetes Complications 02/2021
1	Inguinal Hernia (Direct Inguinal Hernia) 01/2021
1	Heart Failure 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Hernia (Hernias) 01/2021
1	Triple Negative Breast Neoplasms 01/2021

Drug/Important Bio-Agent (IBA)

11	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2004
11	Podophyllotoxin (Condylox)FDA LinkGeneric 01/2019 - 11/2003
10	Pharmaceutical PreparationsIBA 03/2022 - 03/2014
10	Biological ProductsIBA 01/2019 - 10/2010
9	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2011
7	Chalcone (Benzalacetophenone)IBA 12/2020 - 08/2010
7	ThiazolesIBA 10/2020 - 12/2014
7	TubulinIBA 08/2019 - 05/2011
6	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 01/2010
5	pyrazoleIBA 02/2019 - 10/2014
5	Etoposide (VP 16)FDA LinkGeneric 01/2018 - 08/2004
5	BenzodiazepinesIBA 01/2018 - 08/2002
5	benzimidazoleIBA 01/2018 - 08/2013
5	Type II DNA Topoisomerases (Topoisomerase II)IBA 11/2015 - 08/2004
4	Carbolines (Beta-Carbolines)IBA 12/2021 - 04/2014
4	ProdrugsIBA 09/2019 - 05/2008
4	2-oxindole (oxindole)IBA 01/2018 - 12/2013
4	FITC-annexin A5IBA 01/2018 - 10/2015
3	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2015
3	combretastatinIBA 01/2022 - 04/2016
3	Tubulin ModulatorsIBA 12/2020 - 10/2018
3	phenstatinIBA 12/2020 - 04/2015
3	EnzymesIBA 07/2020 - 07/2008
3	TankyrasesIBA 07/2020 - 01/2014
3	benzothiazoleIBA 11/2019 - 01/2017
3	OxindolesIBA 01/2019 - 07/2014
3	LigandsIBA 01/2019 - 01/2012
3	imidazopyridineIBA 10/2018 - 12/2013
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018 - 01/2014
3	IminesIBA 01/2018 - 10/2004
3	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2016 - 01/2016
3	pyrrolo(2,1-c)(1,4)benzodiazepineIBA 12/2013 - 10/2003
3	pyrimidineIBA 10/2013 - 08/2012
2	InterferonsIBA 02/2022 - 01/2018
2	Antiviral Agents (Antivirals)IBA 02/2022 - 03/2021
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 02/2022 - 11/2020
2	OxadiazolesIBA 01/2021 - 10/2014
2	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 01/2017
2	5,5',6,6'- tetrachloro- 1,1',3,3'- tetraethylbenzimidazolocarbocyanineIBA 12/2019 - 01/2018
2	Annexin A5IBA 12/2019 - 01/2018
2	fosbretabulin (combretastatin A4)IBA 09/2019 - 10/2014
2	CCAAT-Enhancer-Binding ProteinsIBA 01/2019 - 08/2018
2	TriazolesIBA 10/2018 - 01/2017
2	QuinazolinonesIBA 08/2018 - 01/2016
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2018 - 11/2015
2	ThiadiazolesIBA 01/2018 - 07/2014
2	Cyclin D1IBA 04/2016 - 06/2010
2	anthranilamideIBA 10/2013 - 08/2012
2	benzamideIBA 09/2013 - 03/2012
2	trioctyl phosphine oxide (TOPO)IBA 12/2010 - 08/2004
1	SofosbuvirIBA 04/2022
1	BilirubinIBA 04/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	SulfonesIBA 01/2022
1	BromidesIBA 01/2022
1	calcipotriene (calcipotriol)FDA LinkGeneric 09/2021
1	betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric 09/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2021
1	Galectin 3 (LGALS3)IBA 03/2021
1	Tumor Biomarkers (Tumor Markers)IBA 03/2021
1	Aldehyde Reductase (Aldose Reductase)IBA 02/2021
1	fidarestatIBA 02/2021
1	phenanthreneIBA 01/2021
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021
1	Neprilysin (Neutral Endopeptidase)IBA 01/2021
1	2,4-thiazolidinedione (thiazolidinedione)IBA 01/2021

Therapy/Procedure

23	Therapeutics 02/2022 - 02/2006
4	Drug Therapy (Chemotherapy) 01/2020 - 05/2010
1	Phototherapy (Light Therapy) 09/2021
1	Radiofrequency Ablation 03/2021
1	Herniorrhaphy 01/2021
1	Operative Surgical Procedures 01/2021